- Home
- PRTA vs USAS Comparison
PRTA vs USAS Comparison
Compare PRTA & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- USAS
- Stock Information
- Founded
- PRTA 2012
- USAS 1998
- Country
- PRTA Ireland
- USAS Canada
- Employees
- PRTA N/A
- USAS N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- USAS Metal Mining
- Sector
- PRTA Health Care
- USAS Basic Materials
- Exchange
- PRTA Nasdaq
- USAS Nasdaq
- Market Cap
- PRTA 472.1M
- USAS 536.1M
- IPO Year
- PRTA N/A
- USAS N/A
- Fundamental
- Price
- PRTA $8.20
- USAS $2.72
- Analyst Decision
- PRTA Buy
- USAS Strong Buy
- Analyst Count
- PRTA 10
- USAS 1
- Target Price
- PRTA $14.86
- USAS $3.25
- AVG Volume (30 Days)
- PRTA 1.2M
- USAS 976.4K
- Earning Date
- PRTA 08-04-2025
- USAS 08-11-2025
- Dividend Yield
- PRTA N/A
- USAS N/A
- EPS Growth
- PRTA N/A
- USAS N/A
- EPS
- PRTA N/A
- USAS N/A
- Revenue
- PRTA $10,341,000.00
- USAS $96,597,000.00
- Revenue This Year
- PRTA N/A
- USAS $29.24
- Revenue Next Year
- PRTA $389.77
- USAS $82.68
- P/E Ratio
- PRTA N/A
- USAS N/A
- Revenue Growth
- PRTA N/A
- USAS N/A
- 52 Week Low
- PRTA $4.32
- USAS $0.55
- 52 Week High
- PRTA $22.83
- USAS $2.85
- Technical
- Relative Strength Index (RSI)
- PRTA 58.73
- USAS 61.69
- Support Level
- PRTA $8.05
- USAS $2.32
- Resistance Level
- PRTA $8.73
- USAS $2.58
- Average True Range (ATR)
- PRTA 0.38
- USAS 0.18
- MACD
- PRTA -0.05
- USAS 0.01
- Stochastic Oscillator
- PRTA 47.62
- USAS 94.57
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.